Jason Higginbotham discussing the Occuity PM1 and AX1 at AECOS London Symposium 2025

Occuity , is pleased to announce that Remidio Innovative Solutions , a leading manufacturer and distributor of ophthalmic medical...

The joy of unboxing a new toy isn’t just for children — sometimes, it’s for researchers too! This time, the toy in question was the...

Occuity is working at the cutting edge of ophthalmological instrumentation, developing machines that have never existed before both as...

Occuity secures CE Marking for PM1 Pachymeter: A Major Milestone for the Company

Occuity awarded prestigious title of National Medtech & Healthtech StartUp of the Year at UK StartUp Awards

Occuity COO, Mark Jenkins and Head of Marketing, Richard Kadri-Langford head to Barcelona to showcase the PM1 and AX1 at ESCRS 2024

Occuity has some great news on our recently filed patents. We’ve now heard that 3 of our new patents have received a “notice of intent to...

Occuity Secures Second Future Leaders Fellowship Award Occuity is thrilled to announce that Dr. Emily J. Patterson has been awarded a...

We are thrilled to announce that Jamie Serjeant, one of our talented engineers, has been honoured with the prestigious RAEng Engineers...

Occuity shortlisted for the LIFE SCIENCES & HEALTH TECH COMPANY OF THE YEAR at the Thames Valley Tech Awards 2024

We’re delighted to announce that Occuity has been selected as a finalist for the Hard Tech Investment of the Year award at the...

World Council of Optometry (WCO) has teamed up with CooperVision to launch an innovative tool designed to set a new standard in myopia manag

We are proud to announce that Occuity has been named the "Medtech & Healthtech StartUp of the Year" in the South East at the UK Startup...

As we approach the end of 2023, it's a fitting time to reflect on Occuity's progress throughout the year. Looking back, it's clear that...

We're very pleased to announce the successful completion of our Convertible Loan Note (CLN) investment round, which reached its target of...

Occuity is pleased to announce the filing of a new patent covering our novel approach to detecting and quantifying biomarkers in the eye....

We are pleased to announce a key milestone in Occuity's technology development strategy has been achieved. One of our recent patents,...

Over the past weekend, some of Occuity's senior leadership team headed to the vibrant city of San Francisco to participate in the eagerly...

Presentation of Internal Results on Investigating Effectiveness of SD1 Prototype to Identify Markers to Screen for Diabetes Occuity has...